Published in J Hepatol on August 26, 2010
Future directions in cancer prevention. Nat Rev Cancer (2012) 1.62
CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PLoS One (2011) 1.00
Predictors of microvascular invasion in patients with solitary small hepatitis B related hepatocellular carcinoma. Pak J Med Sci (2014) 0.80
Epitope-optimized alpha-fetoprotein genetic vaccines prevent carcinogen-induced murine autochthonous hepatocellular carcinoma. Hepatology (2014) 0.80
Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects. Immunotherapy (2014) 0.78
The immunogenicity of the tumor-associated antigen α-fetoprotein is enhanced by a fusion with a transmembrane domain. J Biomed Biotechnol (2012) 0.78
Triple-controlled oncolytic adenovirus expressing melittin to exert inhibitory efficacy on hepatocellular carcinoma. Int J Clin Exp Pathol (2015) 0.77
Hepatokines: unlocking the multi-organ network in metabolic diseases. Diabetologia (2015) 2.05
The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4-like family. Cardiovasc Res (2007) 2.03
Fibrillar collagen scoring by second harmonic microscopy: a new tool in the assessment of liver fibrosis. J Hepatol (2010) 1.88
Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption. Hepatology (2004) 1.58
Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years. Gastroenterology (2011) 1.51
Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am J Pathol (2009) 1.49
Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats. Gastroenterology (2010) 1.48
Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther (2002) 1.39
Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood (2005) 1.38
Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. J Cell Mol Med (2009) 1.36
Gene therapy of the brain in the dog model of Hurler's syndrome. Ann Neurol (2006) 1.32
Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology (2009) 1.31
Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. Hepatology (2008) 1.31
Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res (2007) 1.26
CXCR7 is up-regulated in human and murine hepatocellular carcinoma and is specifically expressed by endothelial cells. Eur J Cancer (2011) 1.26
The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr Cancer Drug Targets (2010) 1.25
Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest (2012) 1.24
Squamous cell carcinoma arising in a hepatic forgut cyst. Pathol Res Pract (2002) 1.23
Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice. J Clin Invest (2007) 1.23
Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology (2007) 1.23
Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology (2006) 1.18
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection. Hepatology (2008) 1.14
Molecular profiling of stroma identifies osteopontin as an independent predictor of poor prognosis in intrahepatic cholangiocarcinoma. Hepatology (2013) 1.11
Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci (2008) 1.08
Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther (2004) 1.08
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin exposure. Mutat Res (2008) 1.08
Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference. Proc Natl Acad Sci U S A (2007) 1.08
Self-assembly and characterization of layered double hydroxide/DNA hybrids. Nano Lett (2006) 1.05
Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. Clin Cancer Res (2009) 1.04
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol (2002) 1.04
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials (2009) 1.02
Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats. Hepatology (2002) 1.02
Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res (2009) 1.01
Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. Hum Gene Ther (2009) 1.01
Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy. Br J Pharmacol (2009) 1.01
Novel mutation in ferroportin 1 gene is associated with autosomal dominant iron overload. J Hepatol (2003) 1.00
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther (2002) 1.00
CCL5 neutralization restricts cancer growth and potentiates the targeting of PDGFRβ in colorectal carcinoma. PLoS One (2011) 1.00
Exploiting synergies between radiation and oncolytic viruses. Curr Opin Mol Ther (2008) 0.99
Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol (2007) 0.99
Mature hepatocytes are the source of small hepatocyte-like progenitor cells in the retrorsine model of liver injury. J Hepatol (2004) 0.99
Severe prenatal renal anomalies associated with mutations in HNF1B or PAX2 genes. Clin J Am Soc Nephrol (2013) 0.98
Trafficking-deficient long QT syndrome mutation KCNQ1-T587M confers severe clinical phenotype by impairment of KCNH2 membrane localization: evidence for clinically significant IKr-IKs alpha-subunit interaction. Heart Rhythm (2009) 0.98
Amphiphilic block copolymers promote gene delivery in vivo to pathological skeletal muscles. Hum Gene Ther (2005) 0.98
Aminobisphosphonate-pretreated dendritic cells trigger successful Vgamma9Vdelta2 T cell amplification for immunotherapy in advanced cancer patients. Cancer Immunol Immunother (2010) 0.97
Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs. Mol Ther (2005) 0.95
Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation. J Gene Med (2005) 0.94
Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2/8 vectors. J Gene Med (2009) 0.93
Hepcidin in iron metabolism. Curr Protein Pept Sci (2005) 0.93
A robust collagen scoring method for human liver fibrosis by second harmonic microscopy. Opt Express (2010) 0.93
Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo. J Immunol (2007) 0.93
Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res (2009) 0.92
Oncolytic viruses in radiation oncology. Radiother Oncol (2011) 0.92
Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice. J Pharmacol Exp Ther (2009) 0.92
Nonionic amphiphilic block copolymers promote gene transfer to the lung. Hum Gene Ther (2005) 0.92
Pathology of hepatic iron overload. World J Gastroenterol (2007) 0.92
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses. Cancer Res (2007) 0.92
Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. Eur J Nucl Med Mol Imaging (2010) 0.92
Non-viral nanosystems for systemic siRNA delivery. Pharmacol Res (2009) 0.91
Delivery of Na/I symporter gene into skeletal muscle using nanobubbles and ultrasound: visualization of gene expression by PET. J Nucl Med (2010) 0.90
Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials (2010) 0.90
The mitochondrial apoptosis-induced channel (MAC) corresponds to a late apoptotic event. J Biol Chem (2004) 0.90
Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res (2004) 0.90
The encapsulation of DNA molecules within biomimetic lipid nanocapsules. Biomaterials (2009) 0.89
Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination. Mol Ther (2006) 0.89
Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Mol Cancer Ther (2008) 0.89
Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy. Clin Cancer Res (2008) 0.88
Pathology of hepatic iron overload. Semin Liver Dis (2011) 0.88
Sex and acquired cofactors determine phenotypes of ferroportin disease. Gastroenterology (2011) 0.88
In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. J Virol (2009) 0.88
Therapy of anemia in kidney failure, using plasmid encoding erythropoietin. Hum Gene Ther (2008) 0.87
Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. Mol Ther (2002) 0.87
Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion? Immunotherapy (2011) 0.86
In vivo cell lineage analysis during chemical hepatocarcinogenesis in rats using retroviral-mediated gene transfer: evidence for dedifferentiation of mature hepatocytes. Lab Invest (2002) 0.86
Increased body iron stores in elite road cyclists. Med Sci Sports Exerc (2002) 0.86
Invariant natural killer T-cell-deficient mice display increased CCl₄ -induced hepatitis associated with CXCL1 over-expression and neutrophil infiltration. Eur J Immunol (2011) 0.85
The use of molecular imaging of gene expression by radiotracers in gene therapy. Expert Opin Biol Ther (2011) 0.85
Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line. Biomaterials (2012) 0.85
DNA/amphiphilic block copolymer nanospheres promote low-dose DNA vaccination. Mol Ther (2009) 0.85
Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors. Cancer Res (2008) 0.85
Preclinical applications of imaging for cancer gene therapy. Expert Rev Mol Med (2006) 0.85
Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair. Mol Ther (2010) 0.85
Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block. Mol Ther (2008) 0.84
Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice. J Pharmacol Exp Ther (2012) 0.84
Direct in vivo cell lineage analysis in the retrorsine and 2AAF models of liver injury after genetic labeling in adult and newborn rats. PLoS One (2009) 0.83
Upregulation of DNA repair genes in active cirrhosis associated with hepatocellular carcinoma. FEBS Lett (2005) 0.83
Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors. Hepatology (2005) 0.83
Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettes. Hum Gene Ther (2004) 0.83
Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats. Mol Ther (2005) 0.83